rs4948256

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.1690-529G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 152,194 control chromosomes in the GnomAD database, including 3,277 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3277 hom., cov: 32)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.744

Publications

9 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.362 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.1690-529G>T
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.1639-529G>T
intron
N/ANP_001191333.1
ANK3
NM_001320874.2
c.1690-529G>T
intron
N/ANP_001307803.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.1690-529G>T
intron
N/AENSP00000280772.1
ANK3
ENST00000373827.6
TSL:1
c.1672-529G>T
intron
N/AENSP00000362933.2
ANK3
ENST00000503366.6
TSL:2
c.1639-529G>T
intron
N/AENSP00000425236.1

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28288
AN:
152076
Hom.:
3283
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0585
Gnomad AMI
AF:
0.282
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.226
Gnomad EAS
AF:
0.376
Gnomad SAS
AF:
0.293
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.221
Gnomad OTH
AF:
0.204
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.186
AC:
28269
AN:
152194
Hom.:
3277
Cov.:
32
AF XY:
0.190
AC XY:
14105
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0584
AC:
2428
AN:
41542
American (AMR)
AF:
0.198
AC:
3026
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
785
AN:
3472
East Asian (EAS)
AF:
0.376
AC:
1941
AN:
5166
South Asian (SAS)
AF:
0.292
AC:
1409
AN:
4826
European-Finnish (FIN)
AF:
0.275
AC:
2912
AN:
10578
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.221
AC:
15005
AN:
68006
Other (OTH)
AF:
0.203
AC:
429
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1123
2246
3368
4491
5614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.210
Hom.:
6566
Bravo
AF:
0.176

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.7
DANN
Benign
0.67
PhyloP100
0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4948256; hg19: chr10-61956912; API